Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers S Yip, YS Butterfield, O Morozova, S Chittaranjan, MD Blough, J An, I Birol, ... The Journal of pathology 226 (1), 7-16, 2012 | 346 | 2012 |
Lactate dehydrogenase A silencing in IDH mutant gliomas C Chesnelong, MM Chaumeil, MD Blough, M Al-Najjar, OD Stechishin, ... Neuro-oncology 16 (5), 686-695, 2014 | 202 | 2014 |
An in vivo patient-derived model of endogenous IDH1-mutant glioma HA Luchman, OD Stechishin, NH Dang, MD Blough, C Chesnelong, ... Neuro-oncology 14 (2), 184-191, 2011 | 196 | 2011 |
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1 T Mazor, C Chesnelong, A Pankov, LE Jalbert, C Hong, J Hayes, ... Proceedings of the National Academy of Sciences 114 (40), 10743-10748, 2017 | 142 | 2017 |
Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring MM Chaumeil, M Radoul, C Najac, P Eriksson, P Viswanath, MD Blough, ... NeuroImage: Clinical 12, 180-189, 2016 | 69 | 2016 |
Precursor states of brain tumor initiating cell lines are predictive of survival in xenografts and associated with glioblastoma subtypes C Cusulin, C Chesnelong, P Bose, M Bilenky, K Kopciuk, JA Chan, ... Stem cell reports 5 (1), 1-9, 2015 | 66 | 2015 |
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival P Guilhamon, C Chesnelong, MM Kushida, A Nikolic, D Singhal, ... Elife 10, e64090, 2021 | 63 | 2021 |
Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line HA Luchman, C Chesnelong, JG Cairncross, S Weiss Neuro-oncology 15 (8), 979-980, 2013 | 47 | 2013 |
ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways F Wang, AY Wang, C Chesnelong, Y Yang, A Nabbi, S Thalappilly, ... Oncogene 37 (3), 286-301, 2018 | 37 | 2018 |
DNA hypermethylation and 1p Loss silence NHE‐1 in oligodendroglioma MD Blough, M Al‐Najjar, C Chesnelong, CE Binding, AD Rogers, ... Annals of neurology 71 (6), 845-849, 2012 | 30 | 2012 |
SLUG directs the precursor state of human brain tumor stem cells C Chesnelong, X Hao, O Cseh, AY Wang, HA Luchman, S Weiss Cancers 11 (11), 1635, 2019 | 19 | 2019 |
Isolation and culture of glioblastoma brain tumor stem cells C Chesnelong, I Restall, S Weiss Brain Tumor Stem Cells: Methods and Protocols, 11-21, 2019 | 15 | 2019 |
Live-Cell imaging assays to study glioblastoma brain tumor stem cell migration and invasion I Restall, DA Bozek, C Chesnelong, S Weiss, HA Luchman JoVE (Journal of Visualized Experiments), e58152, 2018 | 12 | 2018 |
Isocitrate Dehydrogenase (IDH) Mutation in Gliomas C Chesnelong Next Generation Sequencing in Cancer Research, Volume 2: From Basepairs to …, 2015 | 2 | 2015 |
STAT3 is a key regulator of an “EMT-like” process mediated by Slug in GBM C Chesnelong, HA Luchman, JG Cairncross, S Weiss Cancer Research 76 (14_Supplement), 2524-2524, 2016 | 1 | 2016 |
STEM-11. POLYAMINE METABOLISM AND INFLAMMATORY STATE CONTROL A VIRAL MIMICRY-DRIVEN QUIESCENT PHENOTYPE IN GLIOMA STEM CELLS (GSCS) C Chesnelong, C Charton, P Dirks Neuro-Oncology 24 (Suppl 7), vii33, 2022 | | 2022 |
Henry Ford Health System Scholarly Common s S Arora, C Bronkema, JR Porter, A Mottrie, M Menon Laboratory Investigation 101 (1), 499-501, 2021 | | 2021 |
Molecular Pathways to Initiation and Progression in Gliomas C Chesnelong | | 2017 |
STAT3 REGULATES AN SL/PL TRANSITION IN BTICs THROUGH AN EMT-LIKE PROCESS MEDIATED BY SLUG C Chesnelong, HA Luchman, JG Cairncross, S Weiss NEURO-ONCOLOGY 18, 39-40, 2016 | | 2016 |
Hyperpolarized C-13 MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring S Ronen, MM Chaumeil, M Radoul, C Najac, P Eriksson, P Viswanath, ... | | 2016 |